Healthcare sector peers ranked by AI committee score · Updated nightly
| Symbol | Company | Sector | Score | Rating | Mkt Cap | P/E | Beta | Compare |
|---|---|---|---|---|---|---|---|---|
| NVST | Envista Holdings | Healthcare | 75.8 | Strong Buy | $4.6B | 48.3 | 0.86 | Compare |
| NVS | Novartis AG | Healthcare | 74.6 | Strong Buy | $293.9B | 23.6 | 0.46 | Compare |
| WST | West Pharmaceutical Services | Healthcare | 73.8 | Strong Buy | $24.7B | 44.6 | 1.14 | Compare |
| ALGN | Align Technology | Healthcare | 73.0 | Strong Buy | $12.4B | 30.0 | 1.65 | Compare |
| INCY | Incyte | Healthcare | 72.4 | Strong Buy | $24.5B | 14.9 | 0.77 | Compare |
| UTHR | United Therapeutics | Healthcare | 71.8 | Strong Buy | $21.9B | 17.1 | 0.56 | Compare |
| GMED | Globus Medical | Healthcare | 70.5 | Strong Buy | $11.5B | 21.4 | 0.95 | Compare |
| MRK | Merck & Co. | Healthcare | 69.7 | Buy | $322.2B | 103.5 | 0.21 | Compare |
| ATR | AptarGroup | Healthcare | 69.4 | Buy | $8.6B | 24.1 | 0.38 | Compare |
| ARGX | argenx SE | Healthcare | 69.4 | Buy | $53.8B | 31.3 | -0.02 | Compare |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 69.2 | Buy | $5.0B | 13.1 | 0.84 | Compare |
| ENSG | Ensign Group | Healthcare | 69.0 | Buy | $10.5B | 27.4 | 0.69 | Compare |
| ZBH | Zimmer Biomet | Healthcare | 68.6 | Buy | $18.8B | 23.5 | 0.46 | Compare |
| ALC | Alcon Inc | Healthcare | 68.2 | Buy | $36.7B | 45.4 | 0.70 | Compare |
| LQDA | Liquidia Corporation | Healthcare | 68.0 | Buy | $7.8B | 368.3 | 0.57 | Compare |
| EXEL | Exelixis | Healthcare | 67.2 | Buy | $12.9B | 15.6 | 0.42 | Compare |
| LNTH | Lantheus Holdings | Healthcare | 67.0 | Buy | $6.6B | 23.9 | -0.06 | Compare |
| PEN | Penumbra, Inc. | Healthcare | 67.0 | Buy | $12.9B | 79.8 | 0.70 | Compare |
| HSIC | Henry Schein | Healthcare | 66.9 | Buy | $10.2B | 25.8 | 0.81 | Compare |
| BFLY | Butterfly Network, Inc. | Healthcare | 66.9 | Buy | $2.5B | -32.4 | 2.08 | Compare |
Why These Stocks?
These companies operate in the same Healthcare sector as BioNTech SE. Rankings are based on the latest AI committee score. View BNTX full analysis →